Rankings
▼
Calendar
BDTX Q4 2021 Earnings — Black Diamond Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
BDTX
Black Diamond Therapeutics, Inc.
$126M
Q4 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$26M
Net Income
-$26M
EPS (Diluted)
$-0.71
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$24M
Free Cash Flow
-$24M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$248M
Total Liabilities
$52M
Stockholders' Equity
$196M
Cash & Equivalents
$66M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$26M
-$23M
-12.5%
Net Income
-$26M
-$23M
-14.3%
← FY 2021
All Quarters
Q1 2022 →